C. Toris, C. Camras, M. Yablonski
Sep 1, 1993
Citations
0
Influential Citations
386
Citations
Quality indicators
Journal
Ophthalmology
Abstract
Purpose: PhXA41, a new phenyl-substituted analog of a prostaglandin F 2α (PGF 2α ) prodrug (13,14-dihydro-17-phenyl-18,19,20-trinor-prostagland in F 2α -1-isopropyl ester), is an effective ocular hypotensive agent in patients with glaucoma. To understand its mechanism of action, various components of aqueous humor dynamics were examined after topical application to human eyes. Methods: In a randomized, double-masked, placebo-controlled study, PhXA41 (0.006%) was given topically twice daily for 1 week to one eye each of 22 volunteers with normotension or ocular hypertension. The other eye was similarly treated with vehicle. Intraocular pressure (IOP) was measured by pneumatonometry and tonographic outflow facility by pneumatonography. Aqueous flow and outflow facility were determined either directly or indirectly by a fluorophotometric technique, and uveoscleral outflow was calculated secondarily. Comparison of values obtained in treated versus contralateral control eyes and on baseline versus day 8 of treatment were made. Results: Compared with baseline measurements, PhXA41 significantly ( P P P Conclusions: PhXA41 decreases IOP in humans by increasing uveoscleral outflow without significantly affecting other parameters of aqueous humor dynamics.